We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Targets Corporate Execs for Off-Label Prosecutions
FDA Targets Corporate Execs for Off-Label Prosecutions
April 30, 2010
The FDA may turn next to misdemeanor prosecutions of pharmaceutical company executives for off-label promotion of their products — based on new agency
standards that are being fine-tuned.